Business Description
Cell MedX Corp
NAICS : 325413
SIC : 3845
ISIN : US15115X1072
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.25 | |||||
Equity-to-Asset | -8.66 | |||||
Debt-to-Equity | -0.45 | |||||
Debt-to-EBITDA | -11.1 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 28.3 | |||||
3-Year EPS without NRI Growth Rate | 19.3 | |||||
3-Year FCF Growth Rate | 38.3 | |||||
3-Year Book Growth Rate | -12.1 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 36.4 | |||||
9-Day RSI | 40.96 | |||||
14-Day RSI | 44.39 | |||||
6-1 Month Momentum % | 36.36 | |||||
12-1 Month Momentum % | 50 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.1 | |||||
Quick Ratio | 0.1 | |||||
Cash Ratio | 0.1 | |||||
Days Payable | 154030 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4 | |||||
Shareholder Yield % | -1.54 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
FCF Margin % | -4633.33 | |||||
ROA % | -170.77 | |||||
ROIC % | -25.58 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -254.34 | |||||
EV-to-EBITDA | -254.34 | |||||
EV-to-Revenue | 2458.67 | |||||
EV-to-FCF | -53.06 | |||||
Earnings Yield (Greenblatt) % | -0.39 | |||||
FCF Yield % | -1.95 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:CMXC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Cell MedX Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.003 | ||
EPS (TTM) ($) | -0.001 | ||
Beta | 7305.11 | ||
Volatility % | 505.15 | ||
14-Day RSI | 44.39 | ||
14-Day ATR ($) | 0.004164 | ||
20-Day SMA ($) | 0.03274 | ||
12-1 Month Momentum % | 50 | ||
52-Week Range ($) | 0.0002 - 0.9312 | ||
Shares Outstanding (Mil) | 297.24 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Cell MedX Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Cell MedX Corp Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Cell MedX Corp Frequently Asked Questions
What is Cell MedX Corp(CMXC)'s stock price today?
When is next earnings date of Cell MedX Corp(CMXC)?
Does Cell MedX Corp(CMXC) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |